The combined use of AZT and Nevirapine for the prevention of Mother-to-Child Transmission of HIV (PMTCT) has a lower risk of inducing antiretroviral resistance.
dc.contributor.author | Van Zyl GU | |
dc.contributor.author | Claassen M | |
dc.contributor.author | Engelbrecht S | |
dc.date.accessioned | 2012-08-10T18:17:34Z | |
dc.date.available | 2012-08-10T18:17:34Z | |
dc.date.issued | 2007 | |
dc.description | Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za | |
dc.description | Geneeskunde | |
dc.description | Geneeskundige Virologie | |
dc.identifier.uri | http://hdl.handle.net/10019.1/41533 | |
dc.title | The combined use of AZT and Nevirapine for the prevention of Mother-to-Child Transmission of HIV (PMTCT) has a lower risk of inducing antiretroviral resistance. | |
dc.type | Proceedings International |